Gross Margin: 99.46%

Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.

Is the gross margin high or low?

The gross margin of 99.46% is 195% above its 5-year average of 33.70%, near the high end of its 5-year range (-89.63%–100.00%).

61.65% above its 12-month average of 61.53%.

XLO Gross Margin Metrics

Gross Margin Analysis

Gross Margin Formula & Definition

Gross Margin = Gross Profit / Revenue

Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Gross Margin FAQ

What is the gross margin for Xilio Therapeutics, Inc. (XLO)?

The gross margin for XLO stock is 99.46%.

Is Xilio Therapeutics, Inc.'s gross margin high or low?

The gross margin of 99.46% is 195% above its 5-year average of 33.70%, near the high end of its 5-year range (-89.63%–100.00%).

What is the TTM average gross margin for Xilio Therapeutics, Inc. (XLO)?

The TTM average gross margin for XLO stock is 61.53%.

What is the 3Y average gross margin for Xilio Therapeutics, Inc. (XLO)?

The 3Y average gross margin for XLO stock is 54.43%.

What is the 5Y average gross margin for Xilio Therapeutics, Inc. (XLO)?

The 5Y average gross margin for XLO stock is 33.70%.

Related Metrics